Global Seasonal Influenza Vaccines Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 09-Jul-2021
No. of pages: 109
Inquire Before Buying

Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world.There are 4 types of seasonal influenza viruses, types A, B, C and D. Influenza A and B viruses circulate and cause seasonal epidemics of disease.

Market Analysis and Insights: Global Seasonal Influenza Vaccines Therapeutics Market

The global Seasonal Influenza Vaccines Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Seasonal Influenza Vaccines Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Seasonal Influenza Vaccines Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Seasonal Influenza Vaccines Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Seasonal Influenza Vaccines Therapeutics market.

Global Seasonal Influenza Vaccines Therapeutics Scope and Market Size

Seasonal Influenza Vaccines Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Influenza Vaccines Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Paediatrics

- Adolescence

- Adults

- Elderly

Segment by Application

- Hospitals

- Clinics

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- GSK

- Novartis

- CSL

- MedImmune

- Sanofi-Pasteur

- Solvay

- Hualan Biological Engineering

- Sinovac Biotech

- Changchun Institute of Biological Products Co., Ltd.

- Shanghai Institute of Biological Products Co., Ltd.

Global Seasonal Influenza Vaccines Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Paediatrics
1.2.3 Adolescence
1.2.4 Adults
1.2.5 Elderly
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2016-2027)
2.2 Seasonal Influenza Vaccines Therapeutics Growth Trends by Regions
2.2.1 Seasonal Influenza Vaccines Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Seasonal Influenza Vaccines Therapeutics Industry Dynamic
2.3.1 Seasonal Influenza Vaccines Therapeutics Market Trends
2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue
3.1.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Seasonal Influenza Vaccines Therapeutics Revenue
3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2020
3.5 Seasonal Influenza Vaccines Therapeutics Key Players Head office and Area Served
3.6 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
3.7 Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type
4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027)
5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application
5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
6.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type
6.2.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application
6.3.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
6.4.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type
7.2.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application
7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
7.4.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type
8.2.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application
8.3.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region
8.4.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
9.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type
9.2.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application
9.3.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country
9.4.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type
10.2.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application
10.3.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country
10.4.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction
11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction
11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 CSL Business Overview
11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction
11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.3.5 CSL Recent Development
11.4 MedImmune
11.4.1 MedImmune Company Details
11.4.2 MedImmune Business Overview
11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction
11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.4.5 MedImmune Recent Development
11.5 Sanofi-Pasteur
11.5.1 Sanofi-Pasteur Company Details
11.5.2 Sanofi-Pasteur Business Overview
11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction
11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.5.5 Sanofi-Pasteur Recent Development
11.6 Solvay
11.6.1 Solvay Company Details
11.6.2 Solvay Business Overview
11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction
11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.6.5 Solvay Recent Development
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Company Details
11.7.2 Hualan Biological Engineering Business Overview
11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Introduction
11.7.4 Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.7.5 Hualan Biological Engineering Recent Development
11.8 Sinovac Biotech
11.8.1 Sinovac Biotech Company Details
11.8.2 Sinovac Biotech Business Overview
11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction
11.8.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.8.5 Sinovac Biotech Recent Development
11.9 Changchun Institute of Biological Products Co., Ltd.
11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Details
11.9.2 Changchun Institute of Biological Products Co., Ltd. Business Overview
11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.9.4 Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Development
11.10 Shanghai Institute of Biological Products Co., Ltd.
11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Details
11.10.2 Shanghai Institute of Biological Products Co., Ltd. Business Overview
11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.10.4 Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Paediatrics
Table 3. Key Players of Adolescence
Table 4. Key Players of Adults
Table 5. Key Players of Elderly
Table 6. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027)
Table 12. Seasonal Influenza Vaccines Therapeutics Market Trends
Table 13. Seasonal Influenza Vaccines Therapeutics Market Drivers
Table 14. Seasonal Influenza Vaccines Therapeutics Market Challenges
Table 15. Seasonal Influenza Vaccines Therapeutics Market Restraints
Table 16. Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020)
Table 19. Ranking of Global Top Seasonal Influenza Vaccines Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
Table 23. Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. GSK Company Details
Table 64. GSK Business Overview
Table 65. GSK Seasonal Influenza Vaccines Therapeutics Product
Table 66. GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 67. GSK Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Seasonal Influenza Vaccines Therapeutics Product
Table 71. Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. CSL Company Details
Table 74. CSL Business Overview
Table 75. CSL Seasonal Influenza Vaccines Therapeutics Product
Table 76. CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 77. CSL Recent Development
Table 78. MedImmune Company Details
Table 79. MedImmune Business Overview
Table 80. MedImmune Seasonal Influenza Vaccines Therapeutics Product
Table 81. MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 82. MedImmune Recent Development
Table 83. Sanofi-Pasteur Company Details
Table 84. Sanofi-Pasteur Business Overview
Table 85. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product
Table 86. Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Sanofi-Pasteur Recent Development
Table 88. Solvay Company Details
Table 89. Solvay Business Overview
Table 90. Solvay Seasonal Influenza Vaccines Therapeutics Product
Table 91. Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Solvay Recent Development
Table 93. Hualan Biological Engineering Company Details
Table 94. Hualan Biological Engineering Business Overview
Table 95. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product
Table 96. Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Hualan Biological Engineering Recent Development
Table 98. Sinovac Biotech Company Details
Table 99. Sinovac Biotech Business Overview
Table 100. Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Sinovac Biotech Recent Development
Table 102. Changchun Institute of Biological Products Co., Ltd. Company Details
Table 103. Changchun Institute of Biological Products Co., Ltd. Business Overview
Table 104. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product
Table 105. Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Changchun Institute of Biological Products Co., Ltd. Recent Development
Table 107. Shanghai Institute of Biological Products Co., Ltd. Company Details
Table 108. Shanghai Institute of Biological Products Co., Ltd. Business Overview
Table 109. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product
Table 110. Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Shanghai Institute of Biological Products Co., Ltd. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Paediatrics Features
Figure 3. Adolescence Features
Figure 4. Adults Features
Figure 5. Elderly Features
Figure 6. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Seasonal Influenza Vaccines Therapeutics Report Years Considered
Figure 11. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players in 2020
Figure 16. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue in 2020
Figure 18. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2016-2027)
Figure 40. China Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 61. CSL Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 62. MedImmune Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 63. Sanofi-Pasteur Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 64. Solvay Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 65. Hualan Biological Engineering Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 66. Sinovac Biotech Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 67. Changchun Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 68. Shanghai Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs